- ¥1tn
- ¥1tn
- ¥742bn
- 82
- 43
- 54
- 66
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 22.39 | ||
| PEG Ratio (f) | 2.09 | ||
| EPS Growth (f) | 12.03% | ||
| Dividend Yield (f) | 4.06% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.32 | ||
| Price to Tang. Book | 2.1 | ||
| Price to Free Cashflow | 686.83 | ||
| Price to Sales | 1.45 | ||
| EV to EBITDA | 9.89 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 6.78% | ||
| Return on Equity | 6.95% | ||
| Operating Margin | 9% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | ¥m | 695,621 | 645,942 | 756,226 | 744,402 | 741,751 | 774,431 | 815,746 | 2.9% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +92.15 | -68.86 | +11.2 | +15.58 | -28.91 | +21.48 | +12.03 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Eisai Co., Ltd. is a Japan-based pharmaceutical company mainly engaged in the research and development, manufacture, sale, import and export of pharmaceuticals. The Company operates in two business segments. The Pharmaceutical segment is engaged in the research, development, manufacture and sale of pharmaceuticals for medical use, generic drugs, general medicines, among others. The segment operates in five regions including Japan, Americas (North America), China, EMEA (Europe, Middle East, Africa, Oceania), Asia and Latin America (South Korea, Taiwan, Hong Kong, India, ASEAN, Latin America). The Others segment is involved in license revenues and pharmaceutical raw materials business. The Company is also engaged in the provision of brands such as the anticancer drugs Lembima and Halaven on the nerve and oncology areas.
Directors
- Yasuhiko Kato CHM (74)
- Haruo Naito CEO (73)
- Ryohei Yanagi CFO (59)
- Yasushi Okada COO (62)
- Mitsuaki Tanaka CCO (59)
- Kenta Takahashi GCN (61)
- Masatomi Akana MEO (54)
- Ivan Cheung MEO (44)
- Yanhui Feng MEO (49)
- Edward Geary MEO (58)
- Gary Hendler MEO (54)
- Terushige Iike MEO (57)
- Hiroyuki Kato MEO (63)
- Kazumasa Nagayama MEO (41)
- Hidenori Yabune MEO (50)
- Tatsuyuki Yasuno MEO (53)
- Yosuke Akita EXO (56)
- Shohei Kanazawa EXO (56)
- Teiji Kimura EXO (58)
- Lynn Kramer EXO (70)
- Teruyuki Masaka EXO (43)
- Masayuki Miyajima EXO (59)
- Hiroyuki Murayama EXO (53)
- Eriko Naito EXO (54)
- Keisuke Naito EXO (32)
- Akiko Nakahama EXO (53)
- Takashi Ohwa EXO (58)
- Sayoko Sasaki EXO (52)
- Alexander Scott EXO (56)
- Kazuhiko Tamura EXO (57)
- Kappei Tsukahara EXO (56)
- Hideki Hayashi DRC (63)
- Yoshiteru Kato DRC (61)
- Yutaka Tsuchiya DRC (69)
- Bruce Aronson IND (69)
- Fumihiko Ike IND (69)
- Shuzo Kaihori IND (73)
- Ryota Miura IND (47)
- Yumiko Miwa IND (55)
- Ryuichi Murata IND (73)
- Hideyo Uchiyama IND (68)
- Last Annual
- March 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- December 6th, 1941
- Public Since
- September 14th, 1961
- No. of Shareholders
- 89,333
- No. of Employees
- 11,067
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
Tokyo Stock Exchange- Shares in Issue
- 282,116,386
- Address
- Eisai Main Bldg., 4-6-10, Koishikawa, BUNKYO-KU, 112-8088
- Web
- https://www.eisai.co.jp/
- Phone
- +81 338173700
- Auditors
- Deloitte Touche Tohmatsu LLC
Upcoming Events for 4523
Eisai Co Ltd Annual Shareholders Meeting
Q1 2026 Eisai Co Ltd Earnings Release
Similar to 4523
ASKA Pharmaceutical Holdings Co
Tokyo Stock Exchange
Astellas Pharma
Tokyo Stock Exchange
Astena Holdings Co
Tokyo Stock Exchange
CanBas Co
Tokyo Stock Exchange
CellSeed
Tokyo Stock Exchange
FAQ
What is the Eisai Co share price?
As of Today at 20:23 UTC, shares in Eisai Co are trading at ¥4,073. This share price information is delayed by 15 minutes.
How has the Eisai Co share price performed this year?
Shares in Eisai Co last closed at ¥4,073 and the price had moved by -34.93% over the past 365 days. In terms of relative price strength the Eisai Co share price has underperformed the Nikkei 225 Index by -31.42% over the past year.
What are the analyst and broker recommendations for Eisai Co?
The overall consensus recommendation for Eisai Co is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Eisai Co dividend yield?
The Eisai Co dividend yield is 3.93% based on the trailing twelve month period.
Does Eisai Co pay a dividend?
Last year, Eisai Co paid a total dividend of ¥160, and it currently has a trailing dividend yield of 3.93%.Looking ahead, the next dividend pay date is 2025-06-01.
When does Eisai Co next pay dividends?
We do not have data on when Eisai Co is to next pay dividends. The historic dividend yield on Eisai Co shares is currently 3.93%.
How do I buy Eisai Co shares?
To buy shares in Eisai Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Eisai Co?
As of the previous close price of ¥4,073, shares in Eisai Co had a market capitalisation of ¥1tn.
Where are Eisai Co shares listed?
Here are the trading details for Eisai Co:
- Country of listing: Japan
- Exchange: TYO
- Ticker Symbol: 4523
What kind of share is Eisai Co?
Based on an overall assessment of its quality, value and momentum Eisai Co is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Eisai Co share price forecast for 2025?
The analyst consensus target price for shares in Eisai Co is ¥5,487. That is 34.72% above the last closing price of ¥4,073.
Analysts covering Eisai Co currently have a consensus Earnings Per Share (EPS) forecast of ¥162 for the next financial year.
Find out moreWhat is the trend in the Eisai Co share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Eisai Co. Over the past six months, its share price has underperformed the Nikkei 225 Index by -14.52%.
As of the last closing price of ¥4,073, shares in Eisai Co were trading -18.24% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Eisai Co PE Ratio?
The Eisai Co PE ratio based on its reported earnings over the past 12 months is 22.39. The shares last closed at ¥4,073.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Eisai Co?
Eisai Co's management team is headed by:
- Yasuhiko Kato - CHM
- Haruo Naito - CEO
- Ryohei Yanagi - CFO
- Yasushi Okada - COO
- Mitsuaki Tanaka - CCO
- Kenta Takahashi - GCN
- Masatomi Akana - MEO
- Ivan Cheung - MEO
- Yanhui Feng - MEO
- Edward Geary - MEO
- Gary Hendler - MEO
- Terushige Iike - MEO
- Hiroyuki Kato - MEO
- Kazumasa Nagayama - MEO
- Hidenori Yabune - MEO
- Tatsuyuki Yasuno - MEO
- Yosuke Akita - EXO
- Shohei Kanazawa - EXO
- Teiji Kimura - EXO
- Lynn Kramer - EXO
- Teruyuki Masaka - EXO
- Masayuki Miyajima - EXO
- Hiroyuki Murayama - EXO
- Eriko Naito - EXO
- Keisuke Naito - EXO
- Akiko Nakahama - EXO
- Takashi Ohwa - EXO
- Sayoko Sasaki - EXO
- Alexander Scott - EXO
- Kazuhiko Tamura - EXO
- Kappei Tsukahara - EXO
- Hideki Hayashi - DRC
- Yoshiteru Kato - DRC
- Yutaka Tsuchiya - DRC
- Bruce Aronson - IND
- Fumihiko Ike - IND
- Shuzo Kaihori - IND
- Ryota Miura - IND
- Yumiko Miwa - IND
- Ryuichi Murata - IND
- Hideyo Uchiyama - IND